Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model

• Emrah Yatkin ,

  Contributed equally to this work with: Emrah Yatkin, Lauri Polari

  Affiliations Functional Foods Forum, University of Turku, Turku, Finland, Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland

  ⨯
• Lauri Polari ,

  Contributed equally to this work with: Emrah Yatkin, Lauri Polari

  Affiliations Functional Foods Forum, University of Turku, Turku, Finland, Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland

  ⨯
• Teemu D. Laajala,

  Affiliation Department of Mathematics and Statistics, University of Turku, Turku, Finland

  ⨯
• Annika Smeds,

  Affiliation Åbo Akademi University, Process Chemistry Centre, Laboratory of Wood and Paper Chemistry, Turku, Finland

  ⨯
• Christer Eckerman,

  Affiliation Åbo Akademi University, Process Chemistry Centre, Laboratory of Wood and Paper Chemistry, Turku, Finland

  ⨯
• Bjarne Holmbom,

  Affiliation Åbo Akademi University, Process Chemistry Centre, Laboratory of Wood and Paper Chemistry, Turku, Finland

  ⨯
• Niina M. Saarinen,

  Affiliations Functional Foods Forum, University of Turku, Turku, Finland, Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland

  ⨯
• Tero Aittokallio,

  Affiliations Department of Mathematics and Statistics, University of Turku, Turku, Finland, Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland

  ⨯
• Sari I. Mäkelä

  * E-mail: sarmak@utu.fi

  Affiliations Functional Foods Forum, University of Turku, Turku, Finland, Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland

  ⨯